動物用寄生虫駆除剤市場-2025年から2030年までの予測

動物用寄生虫駆除剤市場は、CAGR 5.51％で2025年の131億9,000万米ドルから2030年には172億5,100万米ドルに成長すると予測されます。

動物用寄生虫駆除剤市場は、2025年から2030年にかけて、ペット飼育率の上昇、動物医療費の増加、人獣共通感染症に対する意識の高まりなどを背景に、大きく成長する見通しです。コンパニオンアニマルや農業動物の外部寄生虫や内部寄生虫の管理に不可欠な寄生虫駆除剤は、動物の健康を増進し、疾病感染を予防する役割を果たすため、需要が高まっています。市場は、厳しい規制政策が課題となっているもの、製品開拓における技術革新と動物福祉を推進する政府の取り組みから恩恵を受けています。

市場促進要因

動物用寄生虫駆除剤市場の主な促進要因は、世界のペット飼育の急増であり、特に都市部では犬や猫のようなコンパニオンアニマルの価値がますます高まっています。この動向は、ペットの健康を確保し、人に感染する病気を予防するために、効果的な寄生虫駆除剤の需要を増大させています。ペットの飼い主や畜産業者が動物の福祉を向上させるために先進的な治療に投資しているため、特に先進地域で動物の健康に対する支出が増加していることが、市場の成長をさらに後押ししています。政府や動物愛護団体のイニシアティブに支えられた、動物伝染病に対する意識の高まりも重要な要因です。このようなキャンペーンは、ノミ、ダニ、回虫、その他の寄生虫によって引き起こされる病気をコントロールする上で、寄生虫駆除剤の重要性を強調しています。さらに、コンパニオンアニマルの疾病管理を強化するために設計された革新的な外部寄生虫駆除剤の開発は、より効果的で的を絞ったソリューションを提供することで、市場の拡大を促進しています。

市場抑制要因

動物用寄生虫駆除剤市場は、製品承認に関する厳しい規制政策による課題に直面しています。これらの規制は安全性と有効性の確保を目的としているため、新規寄生虫駆除剤の市場参入を遅らせ、開発コストと開発期間を増大させる可能性があります。多様な地域規格への準拠は、メーカー、特に中小企業の市場参入をさらに複雑にしています。さらに、先進的な寄生虫駆除薬は高価であるため、新興国市場など価格に敏感な市場では導入が制限される可能性があります。市場の持続的成長には、規制プロセスの合理化と費用対効果の高い技術革新を通じてこれらの課題に対処することが不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 市場スナップショット

• 市場概要
• 市場の定義
• 調査範囲
• 市場セグメンテーション

第3章 ビジネス情勢

• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析
• 業界バリューチェーン分析
• ポリシーと規制
• 戦略的提言

第4章 技術展望

第5章 動物用寄生虫駆除剤市場：製品タイプ別

• イントロダクション
• 外部寄生虫駆除剤
• 内部寄生虫駆除剤
• エンデクトサイド

第6章 動物用寄生虫駆除剤市場：寄生虫タイプ別

• イントロダクション
• 内部
• 外部
  • ダニ
  • ノミ
  • その他

第7章 動物用寄生虫駆除剤市場：投与方法別

• イントロダクション
• 経口
• 注射剤

第8章 動物用寄生虫駆除剤市場：動物タイプ別

• イントロダクション
• コンパニオンアニマル
• 家畜
  • 牛
  • 家禽
  • 豚
  • その他

第9章 動物用寄生虫駆除剤市場：地域別

• イントロダクション
• 北米
  • 製品タイプ別
  • 寄生虫タイプ別
  • 投与方法別
  • 動物タイプ別
  • 国別
    • 米国
    • カナダ
    • メキシコ
• 南米
  • 製品タイプ別
  • 寄生虫タイプ別
  • 投与方法別
  • 動物タイプ別
  • 国別
    • ブラジル
    • アルゼンチン
    • その他
• 欧州
  • 製品タイプ別
  • 寄生虫タイプ別
  • 投与方法別
  • 動物タイプ別
  • 国別
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • その他
• 中東・アフリカ
  • 製品タイプ別
  • 寄生虫タイプ別
  • 投与方法別
  • 動物タイプ別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • その他
• アジア太平洋
  • 製品タイプ別
  • 寄生虫タイプ別
  • 投与方法別
  • 動物タイプ別
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • インドネシア
    • タイ
    • その他

第10章 競合環境と分析

• 主要企業と戦略分析
• 市場シェア分析
• 合併、買収、合意およびコラボレーション
• 競合ダッシュボード

第11章 企業プロファイル

• Boehringer Ingelheim GmbH
• Elanco
• Virbac Corporation
• Merck & Co., Inc.
• Zoetis
• Vetoquinol S.A.
• Ceva Sante Animale
• Perrigo Company Plc,
• Norbrook Laboratories
• Bimeda Inc.

第12章 付録

• 通貨
• 前提条件
• 基準年と予測年のタイムライン
• 利害関係者にとっての主なメリット
• 調査手法
• 略語

The animal parasiticides marketis expected to grow from USD13.190 billion in 2025 to USD17.251 billion in 2030, at a CAGR of 5.51%.

The animal parasiticides market is poised for significant growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Parasiticides, critical for managing ecto- and endoparasites in companion and agricultural animals, are seeing heightened demand due to their role in enhancing animal health and preventing disease transmission. The market benefits from innovations in product development and government initiatives promoting animal welfare, though stringent regulatory policies pose challenges.

Market Drivers

The primary driver of the animal parasiticides market is the global surge in pet adoption, particularly in urban areas, where companion animals like dogs and cats are increasingly valued. This trend has amplified the demand for effective parasiticides to ensure pet health and prevent diseases transmissible to humans. Rising animal health expenditure, especially in developed regions, further fuels market growth, as pet owners and livestock producers invest in advanced treatments to improve animal welfare. Growing awareness of animal-transmitted diseases, supported by initiatives from governments and animal welfare organizations, is another key factor. These campaigns emphasize the importance of parasiticides in controlling diseases caused by fleas, ticks, worms, and other parasites. Additionally, the development of innovative ectoparasiticides, designed to enhance disease management in companion animals, is driving market expansion by offering more effective and targeted solutions.

Market Restraints

The animal parasiticides market faces challenges due to stringent regulatory policies governing product approvals. These regulations, aimed at ensuring safety and efficacy, can delay market entry for new parasiticides, increasing development costs and timelines. Compliance with diverse regional standards further complicates market access for manufacturers, particularly smaller players. Additionally, the high cost of advanced parasiticides may limit adoption in price-sensitive markets, such as developing regions, where affordability is a key concern. Addressing these challenges through streamlined regulatory processes and cost-effective innovations will be essential for sustained market growth.

Market Segmentation

By Product Type

The market is segmented into ectoparasiticides, endoparasiticides, and endectocides. Ectoparasiticides, targeting external parasites like fleas and ticks, hold a significant share due to their widespread use in companion animals. Endoparasiticides, which address internal parasites like worms, are critical for both companion and agricultural animals. Endectocides, offering dual action against internal and external parasites, are gaining traction for their versatility and efficiency.

By Animal Type

The market serves companion animals (e.g., dogs, cats) and agricultural animals (e.g., cattle, poultry). The companion animal segment dominates, driven by rising pet ownership and increased spending on pet healthcare. The agricultural animal segment is also significant, as parasiticides are essential for maintaining livestock health and productivity, particularly in regions with intensive farming.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads, driven by high animal health expenditure, particularly in the United States, and widespread pet adoption. The region's advanced veterinary infrastructure and effective disease management practices further support market dominance. Asia-Pacific is expected to grow rapidly, fueled by increasing pet ownership, rising livestock production, and growing awareness of zoonotic diseases in countries like China and India. Europe, South America, and the Middle East and Africa are also poised for growth, supported by improving veterinary services and regulatory frameworks.

Key Industry Players

The competitive landscape includes leading companies focused on innovation and market expansion. These players are investing in research and development to create advanced parasiticides and strengthen their market positions through strategic partnerships and product launches.

The animal parasiticides market is set for lucrative growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Despite challenges from stringent regulations and high costs, the market's outlook remains positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative, cost-effective solutions and regulatory compliance to capitalize on the growing demand for parasiticides in both companion and agricultural animal sectors.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The animal parasiticides market is analyzed into the following segments:

By Product Type

• Ectoparasiticides
• Endoparasiticides
• Endectocides

By Parasite Type

• External
• Internal

By Mode of Administration

• Oral
• Injectables

By Animal Type

• Companion Animal
• Livestock Animals

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANIMAL PARASITICIDES MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Ectoparasiticides
• 5.3. Endoparasiticides
• 5.4. Endectocides

6. ANIMAL PARASITICIDES MARKET BY PARASITE TYPE

• 6.1. Introduction
• 6.2. Internal
• 6.3. External
  • 6.3.1. Ticks
  • 6.3.2. Fleas
  • 6.3.3. Others

7. ANIMAL PARASITICIDES MARKET BY MODE OF ADMINISTRATION

• 7.1. Introduction
• 7.2. Oral
• 7.3. Injectable

8. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE

• 8.1. Introduction
• 8.2. Companion Animals
• 8.3. Livestock Animals
  • 8.3.1. Cattle
  • 8.3.2. Poultry
  • 8.3.3. Swine
  • 8.3.4. Others

9. ANIMAL PARASITICIDES MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Product Type
  • 9.2.2. By Parasite Type
  • 9.2.3. By Mode of Administration
  • 9.2.4. By Animal Type
  • 9.2.5. By Country
    • 9.2.5.1. USA
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Product Type
  • 9.3.2. By Parasite Type
  • 9.3.3. By Mode of Administration
  • 9.3.4. By Animal Type
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Product Type
  • 9.4.2. By Parasite Type
  • 9.4.3. By Mode of Administration
  • 9.4.4. By Animal Type
  • 9.4.5. By Country
    • 9.4.5.1. Germany
    • 9.4.5.2. France
    • 9.4.5.3. United Kingdom
    • 9.4.5.4. Spain
    • 9.4.5.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Product Type
  • 9.5.2. By Parasite Type
  • 9.5.3. By Mode of Administration
  • 9.5.4. By Animal Type
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. UAE
    • 9.5.5.3. Israel
    • 9.5.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. By Product Type
  • 9.6.2. By Parasite Type
  • 9.6.3. By Mode of Administration
  • 9.6.4. By Animal Type
  • 9.6.5. By Country
    • 9.6.5.1. China
    • 9.6.5.2. India
    • 9.6.5.3. Japan
    • 9.6.5.4. South Korea
    • 9.6.5.5. Indonesia
    • 9.6.5.6. Thailand
    • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Boehringer Ingelheim GmbH
• 11.2. Elanco
• 11.3. Virbac Corporation
• 11.4. Merck & Co., Inc.
• 11.5. Zoetis
• 11.6. Vetoquinol S.A.
• 11.7. Ceva Sante Animale
• 11.8. Perrigo Company Plc,
• 11.9. Norbrook Laboratories
• 11.10. Bimeda Inc.

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations